Available Doses & Pricing - Order Today
Complete Mounjaro Stock Available Now
EverydayMeds maintains full UK inventory of all Mounjaro doses specifically for patients managing binge eating disorder. Unlike other suppliers experiencing shortages, our GPhC-registered pharmacy confirmed stock availability across the complete tirzepatide range. From starter 2.5mg pens at £129.99 (first order) through to maintenance 15mg doses at £278.99, every strength is ready for immediate prescription fulfilment.
Current In-Stock Pricing
Single pen prices start from £169.99 (2.5mg) with first-order discounts bringing costs down to £129.99 using code FIRST40. Popular bundle options include our Intro Duo (2.5mg + 5mg pens) at £299.99 for new patients, providing seamless dose escalation support. The Progress Trio bundle offers 5mg, 7.5mg and 10mg pens for £634.99, ensuring continuous treatment without reordering delays.
Why Choose EverydayMeds for Mounjaro
Our dedicated UK supply chain eliminates the availability anxiety affecting other online pharmacies. We've invested in maintaining comprehensive tirzepatide stock levels specifically because we understand how crucial treatment continuity is for binge eating disorder management. Standard clinical assessments complete within 3 working days, or upgrade to express 24-hour approval when you need treatment urgently.
Immediate Prescription Processing
Once your clinical assessment approves Mounjaro for binge eating support, we dispatch immediately from our UK facility. This prescription-only medicine requires qualified medical review, but our streamlined process ensures you're not left waiting for stock to arrive from overseas suppliers. Every pen includes full patient information and injection guidance.
Reliable Treatment Continuity
Binge eating disorder management requires consistent medication access. Our stock availability means you can confidently start your tirzepatide treatment knowing follow-up doses will be available when needed. Returning customers receive £25 off every order, making ongoing treatment more affordable while maintaining the same immediate dispatch service.
